More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence

Affiliations

• ¹ Department of Dermatology, Liverpool Hospital, Liverpool, New South Wales, Australia; Laboratory of Translational Cutaneous Medicine, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia; School of Clinical Medicine, University of New South Wales Medicine and Health, Sydney, New South Wales, Australia. Electronic address: james.pham@unsw.edu.au.
• ² Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine and Health, University of Zurich, Zurich, Switzerland.
• ³ Department of Dermatology, Liverpool Hospital, Liverpool, New South Wales, Australia; Laboratory of Translational Cutaneous Medicine, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia; School of Clinical Medicine, University of New South Wales Medicine and Health, Sydney, New South Wales, Australia.